In their Review (Münzel, T. et al. Nicotine-containing products and the cardiovascular system: mechanisms and global health implications. Nat. Rev. Cardiol. https://doi.org/10.1038/s41569-026-01331-6; 2026)1, Münzel and colleagues highlight the potential cardiovascular risks associated with nicotine-containing products. The Review covers both tobacco and non-tobacco nicotine-containing consumer products, including e-cigarettes and nicotine pouches.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Ivan Berlin
Prazosina y ciproheptadina en combinación en el tratamiento del trastorno por consumo de alcohol
Antecedentes y objetivos Los estudios preclínicos sugieren que el bloqueo simultáneo de los receptores α1b y 5HT2A puede ser eficaz para reducir el consumo de alcohol. Este estudio tuvo como objetivo evaluar la eficacia y seguridad de la combinación de prazosina (bloqueador α1b) y ciproheptadina (bloqueador 5HT2A) para disminuir el consumo total de alcohol (TAC) en el trastorno por consumo de alcohol (AUD).
Prazosin and cyproheptadine in combination in the treatment of alcohol use disorder: A randomized, double‐blind, placebo‐controlled trial
INTRODUCTION The addictive properties of alcohol and other addictive substances are generally considered to be mediated by an increased release of dopamine in the ventral striatum [1]. Evidence indicates the implication of both α1b-adrenergic and 5HT2A serotonergic receptors in dopamine-mediated behavioural and rewarding responses to psychostimulants and opiates [2].
Electronic Nicotine-Delivery Systems for Smoking Cessation
February 15, 2024 N Engl J Med 2024; 390:601-610 DOI: 10.1056/NEJMoa2308815 Abstract Electronic nicotine-delivery systems — also called e-cigarettes — are used by some tobacco smokers to assist with quitting. Evidence regarding the efficacy and safety of these systems is needed.
Electronic Nicotine-Delivery Systems for Smoking Cessation
Abstract Electronic nicotine-delivery systems — also called e-cigarettes — are used by some tobacco smokers to assist with quitting. Evidence regarding the efficacy and safety of these systems is needed.
Unavailability of varenicline: a global tragedy for the fight against the tobacco epidemic
In July, 2021, Pfizer halted Chantix (varenicline) production due to a nitrosamine impurity. In September, 2021, Pfizer recalled all lots of the medication, effectively making it unavailable indefinitely. Varenicline is a first-line treatment for tobacco cessation and a WHO essential medicine. This drug received approval in 116 countries worldwide. Now, varenicline is largely unavailable worldwide and fully unavailable in the UK, EU, Japan, South America, and most of North America.
The adverse effects of maternal smoking during pregnancy are well known. Pregnant women who smoke are at higher risk of miscarriage, fetal death, prematurity and low birth weight. Smoking during pregnancy also affects the health of the child, as it increases the risk of asthma, psychiatric disorders, and obesity. Even if pregnant women are aware of the health risks, they may continue to smoke.
Grossesse et tabac : les incitations financières multiplient par deux le niveau d’abstinence
Les effets délétères du tabagisme maternel pendant la grossesse sont bien connus. Les femmes enceintes qui fument s’exposent à un risque plus élevé de fausses couches, de mort fœtale, de prématurité et de faible poids de naissance. Le tabagisme pendant la grossesse a aussi un retentissement sur la santé de l’enfant, car il accroît le risque d’avoir de l’asthme, des troubles psychiatriques, ainsi que d’être obèse.
Electronic nicotine delivery systems could be a promising nicotine replacement therapy if we had medication licensing level knowledge about them. Re: Should e-cigarettes be licensed as medicines?
Dear Editor: Should electronic cigarettes be licensed as medicines has been debated when elaborating the report of the Haut Conseil de la Santé Publique (High Council of Public Health), France, published on 4 January 2022 (1). The report expresses the view that current knowledge on the benefit/risk ratio of electronic cigarettes is far from the exigence of medication level licensing and, as a consequence, it does not suggest its use by health care professionals.
Financial incentives for smoking cessation in pregnancy: multicentre randomised controlled trial
Research Financial incentives...
International expert consensus on electronic nicotine delivery systems and heated tobacco products: a Delphi survey
International expert consensus on electronic nicotine delivery systems and heated tobacco products: a Delphi survey http://orcid.org/0000-0002-5928-5616Ivan Berlin1,2, Isabelle Jacot-Sadowski2, Jean-Paul Humair3, Jacques Cornuz2 1 Département de Pharmacologie, Hôpital Pitié-Salpêtrière-Sorbonne Université, Paris, France 2 Centre universitaire de médecine générale et santé publique UNISANTE, Université de Lausanne, Faculte de biologie et médecine, Lausanne, Switzerland 3 Service de médecine de...
Risk of COVID-19 and smoking
Risk of COVID-19 and smoking Free http://orcid.org/0000-0002-5928-5616Ivan Berlin1,2 1 Department of Pharmacology, Hôpital Pitié-Salpêtrière-Sorbonne Université, Paris, France 2 Centre Universitaire de Médecine Générale et Santé Publique, UNISANTE, Université de Lausanne Faculté de Biologie et Médecine, Lausanne, Switzerland Correspondence to Dr Ivan Berlin, Department of pharmacology, Hôpital Pitié-Salpêtrière-Sorbonne Université, Paris 75013, France; ivan.berlin{at}aphp.fr Statistics from...
Risk of COVID-19 and smoking
Risk of COVID-19 and smoking Free http://orcid.org/0000-0002-5928-5616Ivan Berlin1,2 1Department of Pharmacology, Hôpital Pitié-Salpêtrière-Sorbonne Université, Paris, France 2Centre Universitaire de Médecine Générale et Santé Publique, UNISANTE, Université de Lausanne Faculté de Biologie et Médecine, Lausanne, Switzerland Correspondence to Dr Ivan Berlin, Department of pharmacology, Hôpital Pitié-Salpêtrière-Sorbonne Université, Paris 75013, France; ivan.berlin{at}aphp.fr Statistics from...
Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches - Claire - - Addiction - Wiley Online Library
Abstract Background and Aims Due to concerns about increased exposure to nicotine, pregnant women using nicotine replacement therapy (NRT) to stop smoking are usually advised to stop using NRT if they relapse to smoking. This study investigated whether this is justified. We compared changes in saliva cotinine from baseline to 2 weeks post‐target quit date pregnant smokers who relapsed to smoking and continued to use their patches having been assigned to use nicotine patches or placebo.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Ivan
Contact Ivan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack